ReviewFrontiers in oncology2022

Targeting phase separation on enhancers induced by transcription factor complex formations as a new strategy for treating drug-resistant cancers.

Ken-Ichi Takayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.